Geratherm Medical AG

Earnings Release • Mar 9, 2012

News Details

Ad-hoc | 9 March 2012 13:38

Geratherm Medical AG: Geratherm Medical Announces Preliminary Financial Figures for 2011

Geratherm Medical AG / Key word(s): Preliminary Results

09.03.2012 13:38

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP Ad hoc: Geratherm Medical Announces Preliminary Financial Figures for
2011

Ad hoc announcement as per Sect. 15 of WpHG (Securities Trading Act)
released by DGAP - an Equity Story AG company. The issuer is responsible
for the contents of this announcement.

Geratherm Medical Announces Preliminary Financial Figures for 2011

• Sales volume EUR 17.4 million +2.2 %

• EBITDA EUR 2.627 million -10.9 %

• EBITDA margin 15.1 % (2010: 17.4 %)

• EBIT EUR 2 million -17.1 %

• Financial result +126 kEUR (2010: +983 kEUR).

• Results from ordinary activities EUR 2.074 million (2010: EUR 3.334
  million).

• Shareholder earnings (EAT) EUR 1.567 million (2010: EUR 2.712
  million).

• Earnings per share 32 EUR cent (2010: 56 EUR cents)

• Proposed dividend 30 EUR cent per share

Geschwenda, 9 March 2012 - Geratherm Medical has posted a sales volume of
EUR 17.4 million for 2011 and thus concluded the year with an operating
result (EBIT) of EUR 1.948 million. Business development was impacted by
the mild weather conditions that prevailed during the 4th quarter of 2012,
the construction of a production facility in Brazil and the new business
segments Respiratory and Cardio/Stroke. Without these factors, the
operating result for 2011 would have been higher by 486 kEUR. While the
financial result is positive with 126 kEUR, it is notably lower than in the
previous year. The temporary depreciation of securities held as at 31
December 2011 had an unfavorable effect.

Claiming the existing loss carry-forwards on the basis of the good separate
financial statements (HGB) results in an increased burden due to deferred
taxes in the amount of 589 kEUR based on IFRS. These have no cash effect,
however. By deducting these deferred taxes, a positive result for the
shareholders of the parent company in the amount of EUR 1.567 million or 32
EUR cent per share was reported.

Because the dividend in the amount of 30 cents is paid entirely from the
investment account (Einlagekonto per German Corporate Tax Law (KStG) §27),
which does not include investments credited to the nominal share capital,
it is paid without the deduction of capital gains tax and solidarity
surtax. For domestic shareholders, the dividend is generally not subject to
taxation.

The preliminary figures are subject to confirmation by the auditors and the
approval of the supervisory board.

The final figures for the 2011 fiscal year and the annual report will be
published on 24 April 2012.

Short company profile:
Geratherm Medical is an internationally operating medical products
enterprise with the business areas 'Temperature Management', 'Cardio' and
'Respiratory'.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations
Fahrenheitstraße 1, 98716 Geschwenda
Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com
Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland
Tel. 036205/98 111 Fax: 036205/98 115
ISIN : DE 000 549 562 6
WKN : 549 562
Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard
Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

Ende der Mitteilung -

09.03.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of Announcement DGAP News-Service

---